Follow
Tumor Targeting
Tumor Targeting: is a cancer treatment that uses drugs.... Targeted therapy works by targeting the cancer's specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. These genes and proteins are found in cancer cells or in cells related to cancer growth, like blood vessel cells.
-
JUN 29, 2015Cancer
While cancer research often focuses on genetic mutations that cause different cancers, a new study published in the jour ...Written By: Ilene SchneiderJUN 26, 2015Cancer
One reason why cancer is so harmful is that it can trick "checkpoint" proteins found on the immune system's T cells, vir ...Written By: Ilene SchneiderJUN 14, 2015Cancer
Oligodendroglioma, which can be an especially aggressive form of brain cancer, may be caused by a genetic mutation. Scie ...Written By: Ilene SchneiderMAY 07, 2015Cancer
About 2.8 percent of women will be diagnosed with endometrial cancer at some point in their lives, according to the Nati ...Written By: Ilene SchneiderAPR 30, 2015Cell & Molecular Biology
Stem cells, which have the prospect of turning into any kind of cell, offer the alluring possibility of generating new t ...Written By: Judy O'RourkeAPR 27, 2015Cancer
More than 100 drugs have been approved to treat cancer, but predicting which ones will help a particular patient is an i ...Written By: Ilene SchneiderAPR 23, 2015Cancer
Men with prostate cancer benefit from treatment with the pioneering drug olaparib - the first cancer drug to target inhe ...Written By: Ilene SchneiderAPR 22, 2015Cell & Molecular Biology
Extracellular vesicles (membrane sacs secreted from cells) have sprung forth as valuable mediators facilitating cells' c ...Written By: Judy O'RourkeAPR 22, 2015Cancer
One of the main sessions at this year's Experimental Biology Conference in Boston was the Tang Prize Award lecture. It w ...Written By: Ilene SchneiderAPR 21, 2015Cancer
Researchers from The University of Manchester working with drug development company Evgen Pharma, have developed a new c ...Written By: Ilene SchneiderAPR 20, 2015Cell & Molecular Biology
Fastening protein-based medical treatments to nanoparticles isn't easy.
With arduous chemistry, scientists ca ...Written By: Will HectorAPR 20, 2015Cancer
Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely ...Written By: Ilene SchneiderAPR 17, 2015Cancer
The first-ever systematic study of the genomes of patients with ALK-negative anaplastic large cell lymphoma (ALCL), a pa ...Written By: Ilene SchneiderAPR 16, 2015Cancer
When it comes to sequencing patients' tumor genomes to personalize cancer therapy, one very important step may be missin ...Written By: Ilene SchneiderAPR 15, 2015Cancer
The human immune system is poised to spring into action at the first sign of a foreign invader, but it often fails to el ...Written By: Ilene SchneiderAPR 14, 2015Cancer
Cancer researchers from the University of Zurich have identified a key signaling pathway in B-cell lymphoma, a malignant ...Written By: Ilene SchneiderAPR 14, 2015Cancer
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has p ...Written By: Robert WoodardAPR 10, 2015Cell & Molecular Biology
U.S. scientists have discovered how tumor cells that mimic blood vessels could help breast cancer to spread around the b ...Written By: Ilene SchneiderAPR 09, 2015Genetics & Genomics
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimat ...Written By: Ilene SchneiderAPR 08, 2015Cancer
Novartis announces that Health Canada has issued a marketing authorization with conditions for Zykadia (ceritinib), a lu ...Written By: Ilene SchneiderAPR 07, 2015Neuroscience
DNA mutations can cause cancer but in some cases, more mutations may mean a better prognosis for patients. A Yale-led co ...Written By: Will HectorAPR 06, 2015Cancer
Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing ge ...Written By: Ilene SchneiderAPR 06, 2015Cancer
Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients' t ...Written By: Ilene SchneiderAPR 06, 2015Cancer
Most of today's anticancer drugs target the DNA or proteins in tumor cells, but a new discovery by University of Califor ...Written By: Robert Woodard
JUN 29, 2015
Cancer
While cancer research often focuses on genetic mutations that cause different cancers, a new study published in the jour
...
Written By:
Ilene Schneider
JUN 26, 2015
Cancer
One reason why cancer is so harmful is that it can trick "checkpoint" proteins found on the immune system's T cells, vir
...
Written By:
Ilene Schneider
JUN 14, 2015
Cancer
Oligodendroglioma, which can be an especially aggressive form of brain cancer, may be caused by a genetic mutation. Scie
...
Written By:
Ilene Schneider
MAY 07, 2015
Cancer
About 2.8 percent of women will be diagnosed with endometrial cancer at some point in their lives, according to the Nati
...
Written By:
Ilene Schneider
APR 30, 2015
Cell & Molecular Biology
Stem cells, which have the prospect of turning into any kind of cell, offer the alluring possibility of generating new t
...
Written By:
Judy O'Rourke
APR 27, 2015
Cancer
More than 100 drugs have been approved to treat cancer, but predicting which ones will help a particular patient is an i
...
Written By:
Ilene Schneider
APR 23, 2015
Cancer
Men with prostate cancer benefit from treatment with the pioneering drug olaparib - the first cancer drug to target inhe
...
Written By:
Ilene Schneider
APR 22, 2015
Cell & Molecular Biology
Extracellular vesicles (membrane sacs secreted from cells) have sprung forth as valuable mediators facilitating cells' c
...
Written By:
Judy O'Rourke
APR 22, 2015
Cancer
One of the main sessions at this year's Experimental Biology Conference in Boston was the Tang Prize Award lecture. It w
...
Written By:
Ilene Schneider
APR 21, 2015
Cancer
Researchers from The University of Manchester working with drug development company Evgen Pharma, have developed a new c
...
Written By:
Ilene Schneider
APR 20, 2015
Cell & Molecular Biology
Fastening protein-based medical treatments to nanoparticles isn't easy.
With arduous chemistry, scientists ca ...
With arduous chemistry, scientists ca ...
Written By:
Will Hector
APR 20, 2015
Cancer
Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely
...
Written By:
Ilene Schneider
APR 17, 2015
Cancer
The first-ever systematic study of the genomes of patients with ALK-negative anaplastic large cell lymphoma (ALCL), a pa
...
Written By:
Ilene Schneider
APR 16, 2015
Cancer
When it comes to sequencing patients' tumor genomes to personalize cancer therapy, one very important step may be missin
...
Written By:
Ilene Schneider
APR 15, 2015
Cancer
The human immune system is poised to spring into action at the first sign of a foreign invader, but it often fails to el
...
Written By:
Ilene Schneider
APR 14, 2015
Cancer
Cancer researchers from the University of Zurich have identified a key signaling pathway in B-cell lymphoma, a malignant
...
Written By:
Ilene Schneider
APR 14, 2015
Cancer
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has p
...
Written By:
Robert Woodard
APR 10, 2015
Cell & Molecular Biology
U.S. scientists have discovered how tumor cells that mimic blood vessels could help breast cancer to spread around the b
...
Written By:
Ilene Schneider
APR 09, 2015
Genetics & Genomics
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimat
...
Written By:
Ilene Schneider
APR 08, 2015
Cancer
Novartis announces that Health Canada has issued a marketing authorization with conditions for Zykadia (ceritinib), a lu
...
Written By:
Ilene Schneider
APR 07, 2015
Neuroscience
DNA mutations can cause cancer but in some cases, more mutations may mean a better prognosis for patients. A Yale-led co
...
Written By:
Will Hector
APR 06, 2015
Cancer
Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing ge
...
Written By:
Ilene Schneider
APR 06, 2015
Cancer
Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients' t
...
Written By:
Ilene Schneider
APR 06, 2015
Cancer
Most of today's anticancer drugs target the DNA or proteins in tumor cells, but a new discovery by University of Califor
...
Written By:
Robert Woodard